Literature DB >> 26468903

Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies.

Laura Pieri1, Philippe Chafey2, Morgane Le Gall2, Guilhem Clary2, Ronald Melki1, Virginie Redeker3.   

Abstract

BACKGROUND: α-Synuclein (α-Syn) fibrils are the main constituent of Lewy bodies and a neuropathological hallmark of Parkinson's disease (PD). The propagation of α-Syn assemblies from cell to cell suggests that they are involved in PD progression. We previously showed that α-Syn fibrils are toxic because of their ability to bind and permeabilize cell membranes. Here, we document the cellular response in terms of proteome changes of SH-SY5Y cells exposed to exogenous α-Syn fibrils.
METHODS: We compare the proteomes of cells of neuronal origin exposed or not either to oligomeric or fibrillar α-Syn using two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry.
RESULTS: Only α-Syn fibrils induce significant changes in the proteome of SH-SY5Y cells. In addition to proteins associated to apoptosis and toxicity, or proteins previously linked to neurodegenerative diseases, we report an overexpression of proteins involved in intracellular vesicle trafficking. We also report a remarkable increase in fibrillar α-Syn heterogeneity, mainly due to C-terminal truncations.
CONCLUSIONS: Our results show that cells of neuronal origin adapt their proteome to exogenous α-Syn fibrils and actively modify those assemblies. GENERAL SIGNIFICANCE: Cells of neuronal origin adapt their proteome to exogenous toxic α-Syn fibrils and actively modify those assemblies. Our results bring insights into the cellular response and clearance events the cells implement to face the propagation of α-Syn assemblies associated to pathology.

Entities:  

Keywords:  2D-DIGE; Parkinson's Disease; Post-translational modifications; Proteomic; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 26468903     DOI: 10.1016/j.bbagen.2015.10.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

Review 2.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

3.  Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.

Authors:  Zachary A Sorrentino; Yuxing Xia; Kimberly-Marie Gorion; Ethan Hass; Benoit I Giasson
Journal:  FEBS Lett       Date:  2020-01-24       Impact factor: 4.124

Review 4.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

5.  Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.

Authors:  Hilal A Lashuel; Anne-Laure Mahul-Mellier; Salvatore Novello; Ramanath Narayana Hegde; Yllza Jasiqi; Melek Firat Altay; Sonia Donzelli; Sean M DeGuire; Ritwik Burai; Pedro Magalhães; Anass Chiki; Jonathan Ricci; Manel Boussouf; Ahmed Sadek; Erik Stoops; Christian Iseli; Nicolas Guex
Journal:  NPJ Parkinsons Dis       Date:  2022-10-20

6.  A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.

Authors:  Jess-Karan S Dhillon; Cara Riffe; Brenda D Moore; Yong Ran; Paramita Chakrabarty; Todd E Golde; Benoit I Giasson
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

7.  Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network.

Authors:  Simona Gribaudo; Philippe Tixador; Luc Bousset; Alexis Fenyi; Patricia Lino; Ronald Melki; Jean-Michel Peyrin; Anselme L Perrier
Journal:  Stem Cell Reports       Date:  2019-01-10       Impact factor: 7.765

8.  Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.

Authors:  Zachary A Sorrentino; Marshall S Goodwin; Cara J Riffe; Jess-Karan S Dhillon; Yuxing Xia; Kimberly-Marie Gorion; Niran Vijayaraghavan; Karen N McFarland; Lawrence I Golbe; Anthony T Yachnis; Benoit I Giasson
Journal:  Acta Neuropathol Commun       Date:  2019-09-02       Impact factor: 7.801

9.  Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.

Authors:  Zachary A Sorrentino; Ethan Hass; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

10.  Structural and functional properties of prefibrillar α-synuclein oligomers.

Authors:  Laura Pieri; Karine Madiona; Ronald Melki
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.